This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wharry, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wharry, S.
Related Collections
Right arrow Other public health
Right arrow Other Complementary Medicine & Alternative Therapies
Right arrow Adverse drug reactions
CMAJ • June 13, 2000; 162 (12)
© 2000 Canadian Medical Association or its licensors

Health Canada sounds warning over St. John's wort

Steven Wharry

CMAJ

Health Canada is warning physicians that a popular herbal remedy for depression could "seriously alter or diminish the effectiveness" of prescription medications.

A study conducted by the National Institutes of Health in Maryland found that St. John's wort (Hypericum perforatum) significantly decreased the presence of indinavir, a protease inhibitor used to treat HIV infection, in the bloodstream. The study found that St. John's wort decreased plasma concentrations of indinavir, possibly by inducing the cytochrome P450 metabolic pathway.

Although the study (Lancet 2000;355:547-8) referred only to indinavir, officials at both the US Food and Drug Administration and Health Canada are urging patients taking St. John's wort concurrently with any retroviral drug to consult their physician. In a letter to physicians, Health Canada also warns that St. John's wort may affect the metabolism of a variety of prescription drugs, including anti-epilepsy agents, oral contraceptives and immunosuppressant, antidepressant and anticoagulant drugs.

"Although drug interaction studies with St. John's wort are not available for antiretroviral agents other than indinavir, the possibility of significant decreases in the blood concentrations of all of the currently marketed HIV-1 protease inhibitors should be considered," warned the letter.

Patients have also developed "serotonin syndrome" by using St. John's wort in combination with conventional antidepressants. The syndrome is characterized by tremors, headaches and restlessness.





This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wharry, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wharry, S.
Related Collections
Right arrow Other public health
Right arrow Other Complementary Medicine & Alternative Therapies
Right arrow Adverse drug reactions